FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Jul 18, 2017
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on July 18, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a78a55a8-8e4d-4695-8d0d-bd3e9d3b1521
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1026192
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of ImpactLife
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 3, 2025 | VAI | Chicago District Office | Blood and Blood Products |
| September 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 1, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1274630 - 2025-07-03
- FDA Inspection 1106877 - 2019-09-12
- FDA Inspection 921394 - 2015-03-26
- FDA Inspection 828694 - 2013-05-01
- FDA Inspection 700491 - 2010-12-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.